Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
Caredx Inc (NASDAQ: CDNA) closed the day trading at $22.81 down -8.43% from the previous closing price of $24.91. In other words, the price has decreased by -$8.43 from its previous closing price. On the day, 1.39 million shares were traded. CDNA stock price reached its highest trading level at $24.94 during the session, while it also had its lowest trading level at $22.6864.
Ratios:
For a better understanding of CDNA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1002.78. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 4.10. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on January 15, 2025, Upgraded its rating to Equal Weight and sets its target price to $24 from $28 previously.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.
BTIG Research Upgraded its Neutral to Buy on August 19, 2024, while the target price for the stock was maintained at $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 04 ’25 when Novack Jeffrey Adam sold 3,512 shares for $23.30 per share. The transaction valued at 81,829 led to the insider holds 104,677 shares of the business.
Jeffrey Adam Novack bought 3,512 shares of CDNA for $81,900 on Feb 04 ’25. On Dec 04 ’24, another insider, Novack Jeffrey Adam, who serves as the Secretary and General Counsel of the company, sold 1,917 shares for $26.00 each. As a result, the insider received 49,842 and left with 110,237 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 1223389184 and an Enterprise Value of 1012500608. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.91 while its Price-to-Book (P/B) ratio in mrq is 4.43. Its current Enterprise Value per Revenue stands at 3.237 whereas that against EBITDA is -22.879.
Stock Price History:
The Beta on a monthly basis for CDNA is 1.94, which has changed by 2.004825 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $7.42. The 50-Day Moving Average of the stock is -0.73%, while the 200-Day Moving Average is calculated to be 4.42%.
Shares Statistics:
Over the past 3-months, CDNA traded about 786.93K shares per day on average, while over the past 10 days, CDNA traded about 872960 shares per day. A total of 53.11M shares are outstanding, with a floating share count of 50.07M. Insiders hold about 6.65% of the company’s shares, while institutions hold 101.58% stake in the company. Shares short for CDNA as of 1738281600 were 4455035 with a Short Ratio of 5.58, compared to 1735603200 on 3969771. Therefore, it implies a Short% of Shares Outstanding of 4455035 and a Short% of Float of 10.95.
